DiaMedica Therapeutics Inc (NAS:DMAC)
$ 4.3 0.125 (2.99%) Market Cap: 183.82 Mil Enterprise Value: 130.15 Mil PE Ratio: 0 PB Ratio: 3.44 GF Score: 40/100

Q2 2020 DiaMedica Therapeutics Inc Earnings Call Transcript

Aug 12, 2020 / 12:00PM GMT
Release Date Price: $5.3 (-1.85%)
Operator

Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Second Quarter 2020 Financial Results Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investors section.

Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information including the factors that could cause actual results to differ from projected results appears in the section entitled Cautionary Statement Note regarding forward-looking statements in the company's press release issued yesterday and under the heading Risk Factors in DiaMedica's previously filed annual report on Form 10-K.

DiaMedica's SEC filings are available at www.sec.gov and on its

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot